Maurice E. Veronese

1.9k total citations
19 papers, 1.6k citations indexed

About

Maurice E. Veronese is a scholar working on Pharmacology, Molecular Biology and Oncology. According to data from OpenAlex, Maurice E. Veronese has authored 19 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Pharmacology, 7 papers in Molecular Biology and 6 papers in Oncology. Recurrent topics in Maurice E. Veronese's work include Pharmacogenetics and Drug Metabolism (15 papers), Drug Transport and Resistance Mechanisms (6 papers) and Metabolism and Genetic Disorders (3 papers). Maurice E. Veronese is often cited by papers focused on Pharmacogenetics and Drug Metabolism (15 papers), Drug Transport and Resistance Mechanisms (6 papers) and Metabolism and Genetic Disorders (3 papers). Maurice E. Veronese collaborates with scholars based in Australia, United States and Sweden. Maurice E. Veronese's co-authors include John O. Miners, Donald Birkett, Michael E. McManus, Wongwiwat Tassaneeyakul, Wichittra Tassaneeyakul, Tommy Andersson, William Trager, Ann Hunter, Robert L. Haining and Allan E. Rettie and has published in prestigious journals such as Journal of Biological Chemistry, Biochemical and Biophysical Research Communications and The American Journal of Cardiology.

In The Last Decade

Maurice E. Veronese

18 papers receiving 1.6k citations

Peers

Maurice E. Veronese
M V Martin United States
S. Ball United States
Deborah J. Newton United States
Deborah Dunbar United States
Robert L. Haining United States
Mitchell A. Hamman United States
M V Martin United States
Maurice E. Veronese
Citations per year, relative to Maurice E. Veronese Maurice E. Veronese (= 1×) peers M V Martin

Countries citing papers authored by Maurice E. Veronese

Since Specialization
Citations

This map shows the geographic impact of Maurice E. Veronese's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Maurice E. Veronese with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Maurice E. Veronese more than expected).

Fields of papers citing papers by Maurice E. Veronese

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Maurice E. Veronese. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Maurice E. Veronese. The network helps show where Maurice E. Veronese may publish in the future.

Co-authorship network of co-authors of Maurice E. Veronese

This figure shows the co-authorship network connecting the top 25 collaborators of Maurice E. Veronese. A scholar is included among the top collaborators of Maurice E. Veronese based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Maurice E. Veronese. Maurice E. Veronese is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Miners, John O., et al.. (1996). Cytochromes P450, 1A2, and 2C9 are responsible for the human hepatic O-demethylation of R- and S-naproxen. Biochemical Pharmacology. 51(8). 1003–1008. 109 indexed citations
2.
Radominska, A, Richard R. Drake, Xiaoyi Zhu, et al.. (1996). Photoaffinity Labeling of Human Recombinant Sulfotransferases with 2-Azidoadenosine 3′,5′-[5′-32P]Bisphosphate. Journal of Biological Chemistry. 271(6). 3195–3199. 4 indexed citations
3.
Haining, Robert L., Ann Hunter, Maurice E. Veronese, William Trager, & Allan E. Rettie. (1996). Allelic Variants of Human Cytochrome P450 2C9: Baculovirus-Mediated Expression, Purification, Structural Characterization, Substrate Stereoselectivity, and Prochiral Selectivity of the Wild-Type and I359L Mutant Forms. Archives of Biochemistry and Biophysics. 333(2). 447–458. 207 indexed citations
4.
Zhu, Xiaoyi, et al.. (1996). cDNA Cloning and expression of a new form of human aryl sulfotransferase. The International Journal of Biochemistry & Cell Biology. 28(5). 565–571. 55 indexed citations
5.
Veronese, Maurice E., et al.. (1994). Heterologous systems for expression of mammalian sulfotransferases. Chemico-Biological Interactions. 92(1-3). 77–85.
6.
Tassaneeyakul, Wichittra, Michael E. McManus, Wongwiwat Tassaneeyakul, et al.. (1994). Caffeine metabolism by human hepatic cytochromes p450: Contributions of 1A2, 2E1 and 3A isoforms. Biochemical Pharmacology. 47(10). 1767–1776. 167 indexed citations
7.
Tassaneeyakul, Wichittra, Donald Birkett, Maurice E. Veronese, et al.. (1994). Direct characterization of the selectivity of furafylline as an inhibitor of human cytochromes P450 1A1 and 1A2. Pharmacogenetics. 4(5). 281–284. 37 indexed citations
8.
Tassaneeyakul, Wongwiwat, Maurice E. Veronese, Donald Birkett, Frank J. Gonzalez, & John O. Miners. (1993). Validation of 4-nitrophenol as an in vitro substrate probe for human liver CYP2E1 using cDNA expression and microsomal kinetic techniques. Biochemical Pharmacology. 46(11). 1975–1981. 115 indexed citations
9.
Veronese, Maurice E., et al.. (1993). Tolbutamide hydroxylation in humans: lack of bimodality in 106 healthy subjects. Pharmacogenetics. 3(2). 86–93. 31 indexed citations
10.
Andersson, Tommy, et al.. (1993). High-performance liquid chromatographic assay for human liver microsomal omeprazole metabolism. Journal of Chromatography B Biomedical Sciences and Applications. 619(2). 291–297. 20 indexed citations
11.
Tassaneeyakul, Wongwiwat, Maurice E. Veronese, Donald Birkett, & John O. Miners. (1993). High-performance liquid chromatographic assay for 4-nitrophenol hydroxylation, a putative cytochrome P-4502E1 activity, in human liver microsomes. Journal of Chromatography B Biomedical Sciences and Applications. 616(1). 73–78. 63 indexed citations
12.
Andersson, Tommy, John O. Miners, Maurice E. Veronese, et al.. (1993). Identification of human liver cytochrome P450 isoforms mediating omeprazole metabolism. British Journal of Clinical Pharmacology. 36(6). 521–530. 196 indexed citations
13.
Tassaneeyakul, Wichittra, Zahurin Mohamed, Donald Birkett, et al.. (1992). Caffeine as a probe for human cytochromes P450. Pharmacogenetics. 2(4). 173–173. 80 indexed citations
14.
Veronese, Maurice E., Peter I. Mackenzie, Christopher J Doecke, et al.. (1991). Tolbutamide and phenytoin hydroxylations by cDNA-expressed human liver cytochrome P4502C9. Biochemical and Biophysical Research Communications. 175(3). 1112–1118. 176 indexed citations
15.
Veronese, Maurice E., et al.. (1990). Validation of the tolbutamide metabolic ratio for population screening with use of sulfaphenazole to produce model phenotypic poor metabolizers. Clinical Pharmacology & Therapeutics. 47(3). 403–411. 86 indexed citations
16.
McManus, Michael E., James S. Felton, Wendy Burgess, et al.. (1989). Activation of the food-derived mutagen 2-amino-1-methyl-6-phenylimidazo[4, 5-b]pyridine by rabbit and human liver microsomes and purified forms of cytochrome P-450. Carcinogenesis. 10(2). 357–363. 54 indexed citations
17.
Miners, John O., et al.. (1988). Tolbutamide hydroxylation by human liver microsomes. Biochemical Pharmacology. 37(6). 1137–1144. 187 indexed citations
18.
Markos, James, et al.. (1985). Value of hepatic computerized tomographic scanning during amiodarone therapy. The American Journal of Cardiology. 56(1). 89–92. 19 indexed citations
19.
Davies, Noel W., Maurice E. Veronese, & Stuart McLean. (1984). Mass spectrometric determination of n-hydroxyphenacetin in urine using multiple metastable peak monitoring following thin-layer chromatography. Journal of Chromatography B Biomedical Sciences and Applications. 310(1). 179–187. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026